See more : Spencer Pharmaceutical Inc. (SPPH) Income Statement Analysis – Financial Results
Complete financial analysis of Halma plc (HLMAF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Halma plc, a leading company in the Conglomerates industry within the Industrials sector.
You may be interested
- Technocraft Industries (India) Limited (TIIL.BO) Income Statement Analysis – Financial Results
- Millicom International Cellular S.A. (TIGOR) Income Statement Analysis – Financial Results
- Wieson Technologies Co., Ltd. (6272.TWO) Income Statement Analysis – Financial Results
- Flow Beverage Corp. (FLOW.TO) Income Statement Analysis – Financial Results
- CX Network Group, Inc. (CXKJ) Income Statement Analysis – Financial Results
Halma plc (HLMAF)
About Halma plc
Halma plc, through its subsidiaries, provides technology solutions in the safety, health, and environmental markets. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire detection, specialist fire suppression, elevator safety, security sensors, people and vehicle flow technologies, specialized interlocks that control critical processes safely, and explosion protection and corrosion monitoring systems. This segment serves elevator safety, fire suppression, people and vehicle flow, fire detection, pressure management, industrial access control, and safe storage and transfer markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; water, air and gases monitoring technologies; instruments that detect hazardous gases and analyses air quality; and systems for water analysis and treatment. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; laboratory devices and systems that provide information to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable positive outcomes across clinical specialties. This segment serves the life sciences, health assessment, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.03B | 1.85B | 1.53B | 1.32B | 1.34B | 1.21B | 1.08B | 961.66M | 807.81M | 726.13M | 676.51M | 619.21M | 579.88M | 518.43M | 459.12M | 455.93M | 395.06M | 351.12M | 310.77M | 268.72M | 292.64M | 267.29M | 267.60M | 268.32M | 233.49M | 217.76M | 213.78M | 200.14M | 173.65M | 153.74M | 135.32M | 116.15M | 94.55M | 81.87M | 78.08M | 61.10M | 50.82M | 36.86M | 31.15M |
| Cost of Revenue | 1.03B | 974.90M | 801.00M | 704.60M | 707.10M | 644.80M | 540.67M | 482.82M | 408.97M | 342.87M | 321.99M | 297.70M | 285.01M | 345.84M | 310.53M | 313.84M | 266.58M | 236.58M | 207.44M | 208.06M | 205.12M | 187.01M | 189.02M | 187.97M | 163.50M | 152.13M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.00B | 877.90M | 724.30M | 613.60M | 631.30M | 566.10M | 535.54M | 478.84M | 398.83M | 383.26M | 354.52M | 321.51M | 294.88M | 172.59M | 148.59M | 142.09M | 128.48M | 114.54M | 103.33M | 60.66M | 87.52M | 80.29M | 78.57M | 80.35M | 69.99M | 65.63M | 213.78M | 200.14M | 173.65M | 153.74M | 135.32M | 116.15M | 94.55M | 81.87M | 78.08M | 61.10M | 50.82M | 36.86M | 31.15M |
| Gross Profit Ratio | 49.35% | 47.38% | 47.49% | 46.55% | 47.17% | 46.75% | 49.76% | 49.79% | 49.37% | 52.78% | 52.40% | 51.92% | 50.85% | 33.29% | 32.36% | 31.16% | 32.52% | 32.62% | 33.25% | 22.57% | 29.91% | 30.04% | 29.36% | 29.94% | 29.98% | 30.14% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 71.20M | 58.60M | 39.50M | 42.60M | 41.10M | 37.65M | 29.12M | 24.07M | 35.43M | 32.31M | 30.36M | 22.71M | 20.95M | 18.30M | 19.06M | 14.84M | 11.42M | 10.95M | 11.76M | 11.24M | 9.62M | 8.21M | 7.99M | 6.75M | 6.42M | 6.03M | 5.62M | 4.57M | 4.29M | 3.68M | 3.16M | 2.78M | 2.25M | 1.94M | 1.27M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 415.40M | 404.40M | 316.70M | 267.90M | 270.10M | 231.50M | 222.60M | 189.58M | 154.08M | 131.54M | 108.12M | 113.17M | 101.09M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.02M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 220.70M | 210.10M | 168.00M | 144.60M | 162.00M | 149.70M | 162.90M | 153.66M | 124.91M | 114.66M | 102.83M | 91.04M | 83.88M | 11.07M | 9.62M | 10.73M | 9.12M | 8.45M | 7.07M | 6.33M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 636.10M | 485.20M | 380.90M | 321.80M | 343.10M | 306.70M | 306.73M | 277.25M | 225.99M | 246.20M | 210.95M | 204.21M | 184.97M | 11.07M | 9.62M | 10.73M | 9.12M | 8.45M | 7.07M | 36.34M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.55M | -2.01M | -1.42M | -1.88M | -470.00K | 0.00 | 0.00 | -2.00M | -759.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -7.77M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.14M | 14.08M | 11.41M | 8.92M | 6.39M | 5.22M |
| Operating Expenses | 636.10M | 556.40M | 439.50M | 361.30M | 385.70M | 347.80M | 344.38M | 306.37M | 250.06M | 246.20M | 210.95M | 204.21M | 184.97M | 73.54M | 64.77M | 66.31M | 59.58M | 50.88M | 44.69M | 11.67M | 27.83M | 34.41M | 30.51M | 30.56M | 18.79M | 24.79M | 166.37M | 163.15M | 140.46M | 124.82M | 110.21M | 95.72M | 77.50M | 81.87M | 78.08M | 61.10M | 50.82M | 36.86M | 31.15M |
| Cost & Expenses | 1.67B | 1.53B | 1.24B | 1.07B | 1.09B | 992.60M | 885.05M | 789.19M | 659.03M | 589.07M | 532.94M | 501.91M | 469.97M | 419.38M | 375.30M | 380.15M | 326.16M | 287.45M | 252.13M | 219.73M | 232.95M | 221.41M | 219.53M | 218.53M | 182.29M | 176.92M | 166.37M | 163.15M | 140.46M | 124.82M | 110.21M | 95.72M | 77.50M | 81.87M | 78.08M | 61.10M | 50.82M | 36.86M | 31.15M |
| Interest Income | 3.10M | 700.00K | 200.00K | 800.00K | 600.00K | 400.00K | 255.00K | 211.00K | 217.00K | 134.00K | 252.00K | 195.00K | 9.74M | 317.00K | 189.00K | 643.00K | 721.00K | 1.04M | 1.03M | 5.66M | 995.00K | 1.22M | 820.00K | 708.00K | 1.09M | 1.62M | 1.00M | 845.00K | 1.09M | 874.00K | 719.00K | 1.36M | 1.06M | 1.10M | 929.00K | 222.00K | 319.00K | 213.00K | 247.00K |
| Interest Expense | 29.60M | 18.30M | 8.70M | 10.80M | 11.70M | 9.00M | 8.15M | 8.14M | 4.71M | 4.58M | 4.74M | 4.06M | 11.23M | 1.25M | 3.05M | 4.06M | 2.87M | 2.86M | 2.85M | 6.72M | 763.00K | 812.00K | 583.00K | 713.00K | 754.00K | 573.00K | 420.00K | 496.00K | 583.00K | 480.00K | 607.00K | 791.00K | 939.00K | 988.00K | 871.00K | 271.00K | 158.00K | 139.00K | 190.00K |
| Depreciation & Amortization | 105.60M | 101.50M | 88.60M | 90.30M | 84.70M | 66.20M | 62.31M | 57.65M | 44.90M | 40.68M | 36.31M | 31.90M | 27.67M | 21.73M | 21.23M | 20.34M | 15.88M | 13.13M | 11.34M | 9.32M | 7.88M | 7.55M | 7.37M | 7.02M | 6.25M | 5.75M | 5.33M | 4.99M | 4.40M | 4.01M | 3.53M | 2.96M | 2.51M | 2.23M | 1.80M | 1.44M | 1.13M | 935.00K | 756.00K |
| EBITDA | 475.50M | 410.60M | 373.40M | 342.60M | 320.60M | 282.30M | 243.20M | 224.04M | 187.39M | 178.87M | 179.73M | 148.41M | 150.87M | 121.27M | 105.36M | 97.19M | 85.58M | 78.15M | 70.83M | 63.99M | 59.04M | 51.64M | 53.91M | 55.50M | 50.77M | 47.87M | 47.97M | 42.57M | 38.60M | 33.72M | 29.21M | 24.64M | 17.67M | 16.47M | 16.81M | 13.07M | 10.37M | 7.54M | 6.22M |
| EBITDA Ratio | 23.38% | 22.83% | 24.48% | 25.99% | 24.68% | 23.49% | 23.55% | 23.93% | 23.98% | 24.43% | 26.58% | 23.97% | 25.35% | 23.40% | 22.95% | 21.24% | 21.66% | 22.17% | 22.85% | 23.81% | 20.17% | 20.47% | 21.02% | 21.44% | 21.74% | 22.14% | 22.44% | 21.40% | 22.28% | 21.99% | 21.70% | 21.30% | 20.33% | 20.12% | 21.52% | 21.39% | 20.40% | 20.45% | 19.98% |
| Operating Income | 367.70M | 321.50M | 284.80M | 252.30M | 245.60M | 218.30M | 191.16M | 172.47M | 148.78M | 137.06M | 143.57M | 117.30M | 109.91M | 99.45M | 84.30M | 76.21M | 70.17M | 63.98M | 58.46M | 49.02M | 46.21M | 42.80M | 45.72M | 47.77M | 42.14M | 40.50M | 41.81M | 36.73M | 33.11M | 28.84M | 24.96M | 20.33M | 15.50M | 14.24M | 15.01M | 11.63M | 9.24M | 6.60M | 5.47M |
| Operating Income Ratio | 18.08% | 17.35% | 18.67% | 19.14% | 18.35% | 18.03% | 17.76% | 17.93% | 18.42% | 18.88% | 21.22% | 18.94% | 18.95% | 19.18% | 18.36% | 16.71% | 17.76% | 18.22% | 18.81% | 18.24% | 15.79% | 16.01% | 17.09% | 17.80% | 18.05% | 18.60% | 19.56% | 18.35% | 19.07% | 18.76% | 18.45% | 17.50% | 16.39% | 17.40% | 19.22% | 19.04% | 18.18% | 17.91% | 17.55% |
| Total Other Income/Expenses | -27.40M | -30.00M | 25.60M | 600.00K | -16.00M | -11.10M | -15.30M | -9.37M | -11.82M | -3.45M | -4.89M | 2.12M | 2.06M | -1.16M | -2.92M | -3.42M | -2.14M | -1.83M | -1.82M | -1.05M | -9.30M | 474.00K | 237.00K | -5.00K | -7.44M | 1.05M | -5.18M | 349.00K | 509.00K | 394.00K | 112.00K | 565.00K | -1.28M | -988.00K | -871.00K | -271.00K | -158.00K | -139.00K | -190.00K |
| Income Before Tax | 340.30M | 291.50M | 304.50M | 252.90M | 224.20M | 206.80M | 172.26M | 157.78M | 136.45M | 133.61M | 138.68M | 120.14M | 111.97M | 98.29M | 81.37M | 72.79M | 68.02M | 62.15M | 56.64M | 47.96M | 36.92M | 43.27M | 45.96M | 47.76M | 34.70M | 41.55M | 36.63M | 37.08M | 33.62M | 29.23M | 25.08M | 20.89M | 14.22M | 13.26M | 14.14M | 11.36M | 9.08M | 6.46M | 5.28M |
| Income Before Tax Ratio | 16.73% | 15.73% | 19.96% | 19.19% | 16.75% | 17.08% | 16.01% | 16.41% | 16.89% | 18.40% | 20.50% | 19.40% | 19.31% | 18.96% | 17.72% | 15.96% | 17.22% | 17.70% | 18.23% | 17.85% | 12.61% | 16.19% | 17.17% | 17.80% | 14.86% | 19.08% | 17.13% | 18.53% | 19.36% | 19.02% | 18.53% | 17.99% | 15.04% | 16.19% | 18.10% | 18.60% | 17.87% | 17.54% | 16.94% |
| Income Tax Expense | 71.50M | 57.20M | 60.20M | 49.60M | 39.70M | 36.90M | 17.72M | 28.01M | 27.45M | 29.61M | 32.35M | 26.53M | 25.26M | 25.86M | 20.94M | 20.21M | 19.69M | 18.45M | 17.03M | 14.47M | 14.59M | 14.91M | 14.80M | 15.64M | 12.69M | 12.96M | 11.85M | 11.97M | 10.69M | 9.42M | 8.29M | 6.47M | 4.55M | 4.09M | 4.56M | 3.73M | 3.24M | 2.28M | 1.93M |
| Net Income | 268.80M | 234.50M | 244.40M | 203.40M | 184.40M | 169.80M | 154.20M | 129.69M | 108.84M | 104.00M | 106.33M | 93.61M | 86.71M | 72.43M | 60.44M | 52.58M | 50.28M | 44.01M | 40.88M | 34.55M | 22.32M | 28.36M | 31.16M | 32.12M | 22.01M | 28.59M | 24.78M | 25.10M | 22.93M | 19.81M | 16.79M | 14.40M | 9.67M | 8.08M | 10.43M | 7.93M | 5.84M | 3.69M | 3.33M |
| Net Income Ratio | 13.21% | 12.66% | 16.02% | 15.43% | 13.78% | 14.02% | 14.33% | 13.49% | 13.47% | 14.32% | 15.72% | 15.12% | 14.95% | 13.97% | 13.16% | 11.53% | 12.73% | 12.53% | 13.15% | 12.86% | 7.63% | 10.61% | 11.64% | 11.97% | 9.43% | 13.13% | 11.59% | 12.54% | 13.20% | 12.89% | 12.41% | 12.40% | 10.23% | 9.87% | 13.35% | 12.97% | 11.50% | 10.00% | 10.68% |
| EPS | 0.71 | 0.62 | 0.65 | 0.54 | 0.49 | 0.45 | 0.41 | 0.34 | 0.29 | 0.27 | 0.28 | 0.25 | 0.23 | 0.19 | 0.16 | 0.14 | 0.13 | 0.12 | 0.11 | 0.09 | 0.06 | 0.08 | 0.09 | 0.09 | 0.06 | 0.08 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 | 0.04 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 |
| EPS Diluted | 0.71 | 0.62 | 0.64 | 0.54 | 0.49 | 0.45 | 0.41 | 0.34 | 0.29 | 0.27 | 0.28 | 0.25 | 0.23 | 0.19 | 0.16 | 0.14 | 0.13 | 0.12 | 0.11 | 0.09 | 0.06 | 0.08 | 0.09 | 0.09 | 0.06 | 0.08 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 | 0.04 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 |
| Weighted Avg Shares Out | 377.30M | 378.00M | 378.70M | 379.16M | 379.09M | 379.16M | 378.99M | 378.69M | 378.41M | 378.33M | 377.81M | 377.60M | 376.93M | 376.61M | 375.49M | 373.83M | 372.77M | 371.22M | 369.05M | 368.18M | 366.24M | 365.41M | 363.10M | 360.65M | 361.34M | 360.97M | 359.99M | 357.51M | 355.86M | 354.07M | 349.56M | 342.92M | 329.82M | 317.50M | 309.45M | 297.83M | 240.59M | 271.71M | 260.41M |
| Weighted Avg Shares Out (Dil) | 378.70M | 379.10M | 379.40M | 379.16M | 379.09M | 379.16M | 378.99M | 378.69M | 378.41M | 378.48M | 378.04M | 378.01M | 377.47M | 377.37M | 376.51M | 374.89M | 374.60M | 374.04M | 370.44M | 368.70M | 366.24M | 365.92M | 364.84M | 361.10M | 362.20M | 362.26M | 361.43M | 357.51M | 355.86M | 354.07M | 349.56M | 342.92M | 329.82M | 317.50M | 309.45M | 297.83M | 240.59M | 271.71M | 260.41M |
Halma rockets higher as numbers impress again
Halma made good progress in its latest year said broker Shore Capital, with record revenue/profit for the 21st consecutive year. Importantly, Halma continues to see good organic momentum and has made a positive start to the current year with a...
Halma shares fly amid record profits and a 45th dividend hike
Halma PLC (LSE:HLMA) shares have lifted 6% at the open after it announced another year of record profits and sales, leading it to raise its dividend for the 45th year in a row. Annual pre-tax profits jumped 10% to £396.4 million...
Dividend hero Halma predicted to raise payout once again
Will FTSE 100-listed safety equipment company Halma PLC (LSE:HLMA) deliver its 45th consecutive 5%-plus dividend increase in its upcoming full-year earnings print? The 130-year-old Amersham-based group may not be among the sexiest of the blue-chip index's constituents, but its investment...
Halma acquires electrical testing developer MK Test
Halma PLC (LSE:HLMA), the safety equipment firm, acquired electrical testing company MK Test for over £40 million, it revealed on Wednesday. MK Test manufactures and develops electrical testing technology to monitor the integrity of high-voltage systems such as those used...
Halma upgrade, Spirax and Weir downgrade; Melrose the pick of litter, says lead investment bank
Shares in Halma Group PLC were up 3.3% in late morning trading after a leading investment bank upgraded its stock recommendation on the safety equipment group. In a short note, UBS said it had moved to 'buy' from 'neutral' and set...
Halma says profits will hit City targets despite modest sales in UK, China
Halma PLC (LSE:HLMA) says it has made "further progress" in the second half of its financial year to 31 March but kept financial guidance unchanged. The FTSE 100-listed safety products group said growth had been strong in the face of "varied market conditions",...
OSB, Halma and Trainline pull into view: Thursday's agenda
Engineer Halma's latest acquisition got a mixed response so it will be hoping for better for its latest update
Limited upside on Halma stock following Rovers takeover - analyst
Shore Capital Markets has downgraded its recommendation on Halma PLC (LSE:HLMA) share from buy to hold following the acquisition of Rovers Medical Devices for £73 million, citing limited upside potential on current spot prices. According to Shore Cap analysis, the...
Halma broadens cancer diagnostics offering with Rovers acquisition
FTSE 100-listed safety equipment group Halma PLC (LSE:HLMA) has acquired Rovers Medical Devices for €85 million (£73 million). Rovers is a Dutch designer and manufacturer of sample collection devices used for preventing and diagnosing cervical cancer.
All You Need to Know About Halma (HLMAF) Rating Upgrade to Strong Buy
Halma (HLMAF) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Source: https://incomestatements.info
Category: Stock Reports